<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24324604</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>12</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period.</ArticleTitle><Pagination><StartPage>e80515</StartPage><MedlinePgn>e80515</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e80515</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0080515</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human Enterovirus 71 and Coxsackie A16 have caused many outbreaks in the last decade in mainland China, resulting in thousands of fatal cases. Seroepidemiology which provides important information to document population immunity is rare in China.</AbstractText><AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">A cross sectional study of Enterovirus 71 (EV71) and Coxsackie A16 (CA16) seroprevalence was carried out in Guangdong, China, pre- and post- the 2010 hand, foot and mouth disease (HFMD) epidemic period. The levels of EV71 and CA16 specific antibodies were evaluated by a microneutralization test and the geometric mean titer (GMT) was calculated and compared. Our results indicated frequent infection by EV71 and CA16 in Guangdong before the 2010 epidemic. Only EV71 neutralizing antibody but not CA16 seroprevalence was significantly increased after the 2010 HFMD epidemic. Children less than 3 years old especially those aged 2 years showed the lowest positive rates for EV71 and CA16 NA before epidemic and the most significantly increased EV71 seroprevalence after epidemic. CA16 GMT values declined after the 2010 epidemic.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results indicate EV71 was the major pathogen of HFMD in Guangdong during the 2010 epidemic. The infection occurs largely in children less than 3 years, who should have first priority to receive an EV71 vaccine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center of Pathogen Detection Research for Emerging Infectious Diseases, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China ; Key Laboratory of Pathogen Detection for Emergency Response, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China ; Key Laboratory of Depository and Application for Pathogenic Microbiology, Guangdong Provincial Centre for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Lina</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Changwen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Hanri</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Dawei</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Cong</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wanly</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Hong</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jinyan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declare that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>12</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24324604</ArticleId><ArticleId IdType="pmc">PMC3850913</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0080515</ArticleId><ArticleId IdType="pii">PONE-D-13-25295</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10: 778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML (2011) The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37: 313&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26: 91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Denizot M, Neal JW, Gasque P (2012) Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets. J Infect 65: 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">22484271</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroleva GA, Lukashev AN, Khudiakova LV, Mustafina AN, Lashkevich VA (2011) [Encephalomyelitis caused by enterovirus type 71 in children]. Vopr Virusol 55: 4&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">21381332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, et al. (2010) The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 14: e1076&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou XN, Zhang XZ, Wang B, Qiu YT (2012) Etiologic and epidemiologic analysis of hand, foot, and mouth disease in Guangzhou city: a review of 4,753 cases. Braz J Infect Dis 16: 457&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">22964289</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Chen LL, Huang PN, Shih SR (2010) Neural pathogenesis of enterovirus 71 infection. Microbes Infect 12: 505&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC (2012) Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol 2: 199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng FY, Li JX, Li XL, Chu K, Zhang YT, et al. (2012) Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother 8: 668&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">22634437</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YP, Liang ZL, Xia JL, Wu JY, Wang L, et al... (2013) Immunogenicity, Safety, and Immune persistence of A Novel Inactivated Human Enterovirus 71 (EV71) Vaccine: A Phase II, Randomized, Double-Blind, Placebo-Controlled trial. J Infect Dis.</Citation><ArticleIdList><ArticleId IdType="pubmed">23922377</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, et al... (2013) Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906269</ArticleId><ArticleId IdType="pubmed">23744508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, Li XL, Mao QY, et al. (2013) Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 381: 2024&#x2013;2032.</Citation><ArticleIdList><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Chiang PS, Luo ST, Huang ML, Liou GY, et al. (2012) Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008&#x2013;09. PLoS Negl Trop Dis 6: e1476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3279337</ArticleId><ArticleId IdType="pubmed">22348156</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan D, van der Sanden S, Zeng H, Li W, Zheng H, et al. (2012) Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998&#x2013;2010. PLoS One 7: e44386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3440427</ArticleId><ArticleId IdType="pubmed">22984501</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X, Huang X, Zhu S, Chen H, Yu Q, et al. (2011) The persistent circulation of enterovirus 71 in People&#x2019;s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6: e25662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181342</ArticleId><ArticleId IdType="pubmed">21980521</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Jiang J, Liu Y, Huang X, Wang P, et al... (2012) Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009. Virus Genes.</Citation><ArticleIdList><ArticleId IdType="pubmed">23080402</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan XF, Gao S, Xia JF, Ye R, Yu H, et al. (2011) Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis 44: 297&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">22176514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, El Khatib NF, Tu S, Ren P, Xu S, et al. (2012) Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J Clin Virol 53: 285&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng T, Huang Y, Yu S, Gu J, Huang C, et al. (2013) Spatial-temporal clusters and risk factors of hand, foot, and mouth disease at the district level in Guangdong Province, China. PLoS One 8: e56943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3578924</ArticleId><ArticleId IdType="pubmed">23437278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LM, Zheng HY, Zheng HZ, Guo X, He JF, et al. (2011) An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis 64: 13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21266750</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudareva S, Schweiger B, Thamm M, Hohle M, Stark K, et al. (2011) Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS One 6: e21340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119048</ArticleId><ArticleId IdType="pubmed">21701598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr AW, Urbanowicz RA, Ball JK (2012) The role of humoral innate immunity in hepatitis C virus infection. Viruses 4: 1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3280516</ArticleId><ArticleId IdType="pubmed">22355450</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Wang M, Chang H, Lu J, Lu B, et al. (2011) Prevalence of antibodies against enterovirus 71 in children from Lu&#x2019;an City in Central China. Jpn J Infect Dis 64: 528&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">22116336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Li L, Liu Y, Ge H, Wang X, et al. (2012) Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China. Virol J 9: 248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545860</ArticleId><ArticleId IdType="pubmed">23102275</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, He J, Zhong H, Ke C, Zhang X, et al. (2012) Temporal trends of influenza A (H1N1) virus seroprevalence following 2009 pandemic wave in Guangdong, China: three cross-sectional serology surveys. PLoS One 7: e38768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3377711</ArticleId><ArticleId IdType="pubmed">22719938</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Huang LM, Kao CL, Lu CY, Shao PL, et al. (2011) Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect 45: 96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Phoon MC, Wu Y, Cutter J, James L, et al. (2011) The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore. BMC Infect Dis 11: 270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198955</ArticleId><ArticleId IdType="pubmed">21988931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman DG (1996) The use of transformation when comparing two means. BMJ 312: 1153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2350653</ArticleId><ArticleId IdType="pubmed">8620137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, et al. (2012) Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 7: e37206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Dong C, Li X, Gao Q, Guo Z, et al. (2012) Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One 7: e46043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3460965</ArticleId><ArticleId IdType="pubmed">23029378</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Zhu S, Guo X, Wang J, Wang D, et al. (2010) Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J 7: 300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989968</ArticleId><ArticleId IdType="pubmed">21050463</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Lin TY, Chiang PS, Li WC, Luo ST, et al. (2010) An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J 29: 1030&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">20543760</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrich S, Weinbrecht A, Schreier E (2009) Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch Virol 154: 1139&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pubmed">19506798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi EE, Phoon MC, Ishak B, Chan SH (2002) Seroepidemiology of human enterovirus 71, Singapore. Emerg Infect Dis 8: 995&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732542</ArticleId><ArticleId IdType="pubmed">12194783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Li N, Yu X, Yao X, Li F, et al. (2011) Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol 157: 37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">21984267</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau HF, Richter M, Doerr HW (2009) Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol 199: 45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>